-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Anterix, Lowers Price Target to $130

Benzinga·08/13/2026 15:18:47
Listen to the news
JP Morgan analyst Sebastiano Petti maintains Anterix (NASDAQ:ATEX) with a Overweight and lowers the price target from $133 to $130.